Publication | Closed Access

In vivo delivery of recombinant human growth hormone from genetically engineered human fibroblasts implanted within Baxter immunoisolation devices

Tissue EngineeringRegenerative MedicineCell-based Drug DeliveryEngineeringGrowth HormoneHuman GrowthMedicineBaxter Immunoisolation DevicesBiofabricationGene DeliveryBiomedical EngineeringCell BiologyHuman FibroblastsFunctional Tissue EngineeringCell EngineeringCell TransplantationVivo Delivery